{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:48:12Z","timestamp":1786632492526,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772971"],"award-info":[{"award-number":["81772971"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders with unclear pathogenesis and limited therapeutic options. Macrophage dysfunction is central to IBD progression, yet how metabolic reprogramming governs macrophage function is poorly defined. Although the proline-rich Akt substrate of 40\u2009kDa (PRAS40) is known to be important in colon cancer, its role in IBD is elusive. We found that PRAS40 mRNA expression was elevated in IBD patients, and its protein expression was similarly increased in IBD mouse models. Global PRAS40 deficiency alleviated IBD symptoms in mice, which was reversed by macrophage elimination. Consistently, myeloid-specific PRAS40 knockout mice recapitulated the protective phenotype in IBD mice. Metabolomic analysis revealed decreased amino acid levels in PRAS40-deficient BMDMs, with leucine and tryptophan identified as key drivers of macrophage polarization. Mechanistically, PRAS40 enhanced the phosphorylation of the transcription factor specificity protein 1 (SP1) to stabilize it through activating ERK and JNK signaling pathways. Upregulated SP1 augmented the transcription of solute carrier family 7 member 5 (SLC7A5), thereby boosting leucine and tryptophan uptake. This subsequently activated mTOR signaling, driving the pro-inflammatory polarization of macrophages. Collectively, PRAS40\/SP1\/SLC7A5 axis drives macrophage pro-inflammatory polarization by enhancing leucine and tryptophan uptake, thereby exacerbating IBD. These findings highlight the importance of amino acid reprogramming in macrophage polarization during IBD progression and propose targeting this axis as a potential therapeutic strategy for IBD.<\/jats:p>","DOI":"10.1038\/s41419-026-08931-7","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:46:19Z","timestamp":1780940779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PRAS40-driven pro-inflammatory macrophage polarization is required for inflammatory bowel disease"],"prefix":"10.1038","volume":"17","author":[{"given":"Chengfei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8254-7664","authenticated-orcid":false,"given":"Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"8931_CR1","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","volume":"383","author":"JT Chang","year":"2020","unstructured":"Chang JT. Pathophysiology of Inflammatory Bowel Diseases. N Engl J Med. 2020;383:2652\u201364.","journal-title":"N Engl J Med"},{"key":"8931_CR2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41575-022-00658-y","volume":"19","author":"TE Adolph","year":"2022","unstructured":"Adolph TE, Meyer M, Schwarzler J, Mayr L, Grabherr F, Tilg H. The metabolic nature of inflammatory bowel diseases. Nat Rev Gastroenterol Hepatol. 2022;19:753\u201367.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8931_CR3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","volume":"20","author":"LM Hegarty","year":"2023","unstructured":"Hegarty LM, Jones GR, Bain CC. Macrophages in intestinal homeostasis and inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2023;20:538\u201353.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8931_CR4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/s41423-023-01081-2","volume":"20","author":"X Zheng","year":"2023","unstructured":"Zheng X, Jiang Q, Han M, Ye F, Wang M, Qiu Y, et al. FBXO38 regulates macrophage polarization to control the development of cancer and colitis. Cell Mol Immunol. 2023;20:1367\u201378.","journal-title":"Cell Mol Immunol"},{"key":"8931_CR5","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.celrep.2019.03.028","volume":"27","author":"X Zhou","year":"2019","unstructured":"Zhou X, Li W, Wang S, Zhang P, Wang Q, Xiao J, et al. YAP Aggravates Inflammatory Bowel Disease by Regulating M1\/M2 Macrophage Polarization and Gut Microbial Homeostasis. Cell Rep. 2019;27:1176\u201389 e5.","journal-title":"Cell Rep"},{"key":"8931_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.mucimm.2022.12.005","volume":"16","author":"X Li","year":"2023","unstructured":"Li X, Zhang B, Zhang X, Yu S, Xue HH, Hu X. TLE3 and TLE4-coordinated colonic macrophage-CD4(+) T cell crosstalk maintains intestinal immune homeostasis. Mucosal Immunol. 2023;16:50\u201360.","journal-title":"Mucosal Immunol"},{"key":"8931_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","volume":"16","author":"YR Na","year":"2019","unstructured":"Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16:531\u201343.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8931_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.695238","volume":"12","author":"MJ Halaby","year":"2021","unstructured":"Halaby MJ, McGaha TL. Amino Acid Transport and Metabolism in Myeloid Function. Front Immunol. 2021;12:695238.","journal-title":"Front Immunol"},{"key":"8931_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fimmu.2014.00532","volume":"5","author":"M Rath","year":"2014","unstructured":"Rath M, Muller I, Kropf P, Closs EI, Munder M. Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages. Front Immunol. 2014;5:532.","journal-title":"Front Immunol"},{"key":"8931_CR10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s41423-022-00925-7","volume":"19","author":"X Shan","year":"2022","unstructured":"Shan X, Hu P, Ni L, Shen L, Zhang Y, Ji Z, et al. Serine metabolism orchestrates macrophage polarization by regulating the IGF1-p38 axis. Cell Mol Immunol. 2022;19:1263\u201378.","journal-title":"Cell Mol Immunol"},{"key":"8931_CR11","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.cmet.2019.01.014","volume":"29","author":"AE Rodriguez","year":"2019","unstructured":"Rodriguez AE, Ducker GS, Billingham LK, Martinez CA, Mainolfi N, Suri V, et al. Serine Metabolism Supports Macrophage IL-1beta Production. Cell Metab. 2019;29:1003\u201311 e4.","journal-title":"Cell Metab"},{"key":"8931_CR12","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ni.3796","volume":"18","author":"PS Liu","year":"2017","unstructured":"Liu PS, Wang H, Li X, Chao T, Teav T, Christen S, et al. alpha-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat Immunol. 2017;18:985\u201394.","journal-title":"Nat Immunol"},{"key":"8931_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature. 2013;496:238\u201342.","journal-title":"Nature"},{"key":"8931_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111196","volume":"125","author":"L Xue","year":"2023","unstructured":"Xue L, Wang C, Qian Y, Zhu W, Liu L, Yang X, et al. Tryptophan metabolism regulates inflammatory macrophage polarization as a predictive factor for breast cancer immunotherapy. Int Immunopharmacol. 2023;125:111196.","journal-title":"Int Immunopharmacol"},{"key":"8931_CR15","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/s42255-024-01115-7","volume":"6","author":"SR Sukka","year":"2024","unstructured":"Sukka SR, Ampomah PB, Darville LNF, Ngai D, Wang X, Kuriakose G, et al. Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution. Nat Metab. 2024;6:1736\u201355.","journal-title":"Nat Metab"},{"key":"8931_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031617","volume":"13","author":"KS Fine","year":"2024","unstructured":"Fine KS, Wilkins JT, Sawicki KT. Circulating Branched Chain Amino Acids and Cardiometabolic Disease. J Am Heart Assoc. 2024;13:e031617.","journal-title":"J Am Heart Assoc"},{"key":"8931_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s42255-024-00984-2","volume":"6","author":"X Zhang","year":"2024","unstructured":"Zhang X, Kapoor D, Jeong SJ, Fappi A, Stitham J, Shabrish V, et al. Identification of a leucine-mediated threshold effect governing macrophage mTOR signalling and cardiovascular risk. Nat Metab. 2024;6:359\u201377.","journal-title":"Nat Metab"},{"key":"8931_CR18","doi-asserted-by":"publisher","first-page":"24514","DOI":"10.1074\/jbc.M704406200","volume":"282","author":"BD Fonseca","year":"2007","unstructured":"Fonseca BD, Smith EM, Lee VH, MacKintosh C, Proud CG. PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex. J Biol Chem. 2007;282:24514\u201324.","journal-title":"J Biol Chem"},{"key":"8931_CR19","doi-asserted-by":"publisher","first-page":"20329","DOI":"10.1074\/jbc.M702636200","volume":"282","author":"N Oshiro","year":"2007","unstructured":"Oshiro N, Takahashi R, Yoshino K, Tanimura K, Nakashima A, Eguchi S, et al. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. J Biol Chem. 2007;282:20329\u201339.","journal-title":"J Biol Chem"},{"key":"8931_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/ncb1547","volume":"9","author":"E Vander Haar","year":"2007","unstructured":"Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH. Insulin signalling to mTOR mediated by the Akt\/PKB substrate PRAS40. Nat Cell Biol. 2007;9:316\u201323.","journal-title":"Nat Cell Biol"},{"key":"8931_CR21","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1158\/0008-5472.CAN-06-4234","volume":"67","author":"SV Madhunapantula","year":"2007","unstructured":"Madhunapantula SV, Sharma A, Robertson GP. PRAS40 deregulates apoptosis in malignant melanoma. Cancer research. 2007;67:3626\u201336.","journal-title":"Cancer research"},{"key":"8931_CR22","first-page":"486","volume":"6","author":"D Lv","year":"2016","unstructured":"Lv D, Liu J, Guo L, Wu D, Matsumoto K, Huang L. PRAS40 deregulates apoptosis in Ewing sarcoma family tumors by enhancing the insulin receptor\/Akt and mTOR signaling pathways. Am J Cancer Res. 2016;6:486\u201397.","journal-title":"Am J Cancer Res"},{"key":"8931_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.102604","volume":"51","author":"Z Qi","year":"2020","unstructured":"Qi Z, Zhang T, Song L, Fu H, Luo H, Wu J, et al. PRAS40 hyperexpression promotes hepatocarcinogenesis. EBioMedicine. 2020;51:102604.","journal-title":"EBioMedicine"},{"key":"8931_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04499-0","volume":"13","author":"T Zhang","year":"2022","unstructured":"Zhang T, Wang Y, Yu H, Zhang T, Guo L, Xu J, et al. PGK1 represses autophagy-mediated cell death to promote the proliferation of liver cancer cells by phosphorylating PRAS40. Cell Death Dis. 2022;13:68.","journal-title":"Cell Death Dis"},{"key":"8931_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s11658-024-00638-x","volume":"29","author":"S Zhao","year":"2024","unstructured":"Zhao S, Hao S, Zhou J, Chen X, Zhang T, Qi Z, et al. mTOR\/miR-142-3p\/PRAS40 signaling cascade is critical for tuberous sclerosis complex-associated renal cystogenesis. Cell Mol Biol Lett. 2024;29:125.","journal-title":"Cell Mol Biol Lett"},{"key":"8931_CR26","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1158\/0008-5472.CAN-11-2254","volume":"72","author":"L Huang","year":"2012","unstructured":"Huang L, Nakai Y, Kuwahara I, Matsumoto K. PRAS40 is a functionally critical target for EWS repression in Ewing sarcoma. Cancer Res. 2012;72:1260\u20139.","journal-title":"Cancer Res"},{"key":"8931_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-025-00594-x","volume":"15","author":"C Zhang","year":"2025","unstructured":"Zhang C, Bo Y, Zhang T, Chen X, Zhang T, Teng H, et al. PRAS40 promotes colorectal cancer stemness by enhancing glycolysis through triggering PGK1 acetylation. Oncogenesis. 2025;15:2.","journal-title":"Oncogenesis"},{"key":"8931_CR28","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3390\/antiox12051083","volume":"12","author":"L Sanjurjo","year":"2023","unstructured":"Sanjurjo L, Castelblanco E, Julve J, Villalmanzo N, Tellez E, Ramirez-Morros A, et al. Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40\/Akt-Dependent Shedding of Soluble CD14. Antioxidants (Basel). 2023;12:1083.","journal-title":"Antioxidants (Basel)"},{"key":"8931_CR29","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3389\/fphar.2019.01561","volume":"10","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Xiao L, Fu W, Tang Y, Lertnimitphun P, Kim N, et al. Gaudichaudione H Inhibits Inflammatory Responses in Macrophages and Dextran Sodium Sulfate-Induced Colitis in Mice. Front Pharmacol. 2019;10:1561.","journal-title":"Front Pharmacol"},{"key":"8931_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41423-024-01171-9","volume":"21","author":"S Liu","year":"2024","unstructured":"Liu S, Wu J, Tong X, Huang LH. A novel target to turn cold tumors into hot tumors: lysosomal 25-hydroxycholesterol activates AMPKalpha and immunosuppressive tumor-associated macrophages. Cell Mol Immunol. 2024;21:801\u20133.","journal-title":"Cell Mol Immunol"},{"key":"8931_CR31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41423-024-01156-8","volume":"21","author":"H Yin","year":"2024","unstructured":"Yin H, Ju Z, Zhang X, Zuo W, Yang Y, Zheng M, et al. Inhibition of METTL3 in macrophages provides protection against intestinal inflammation. Cell Mol Immunol. 2024;21:589\u2013603.","journal-title":"Cell Mol Immunol"},{"key":"8931_CR32","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.3390\/ijms24054814","volume":"24","author":"G Lucarelli","year":"2023","unstructured":"Lucarelli G, Netti GS, Rutigliano M, Lasorsa F, Loizzo D, Milella M, et al. MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation. Int J Mol Sci. 2023;24:4814.","journal-title":"Int J Mol Sci"},{"key":"8931_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.129646","volume":"260","author":"R Xia","year":"2024","unstructured":"Xia R, Peng HF, Zhang X, Zhang HS. Comprehensive review of amino acid transporters as therapeutic targets. Int J Biol Macromol. 2024;260:129646.","journal-title":"Int J Biol Macromol"},{"key":"8931_CR34","doi-asserted-by":"publisher","first-page":"22126","DOI":"10.1074\/jbc.M010740200","volume":"276","author":"M Nicolas","year":"2001","unstructured":"Nicolas M, Noe V, Jensen KB, Ciudad CJ. Cloning and characterization of the 5\u2019-flanking region of the human transcription factor Sp1 gene. J Biol Chem. 2001;276:22126\u201332.","journal-title":"J Biol Chem"},{"key":"8931_CR35","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2024.03.011","volume":"187","author":"T Cao","year":"2024","unstructured":"Cao T, Zhang W, Wang Q, Wang C, Ma W, Zhang C, et al. Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8(+) T cells. Cell. 2024;187:2288\u2013304 e27.","journal-title":"Cell"},{"key":"8931_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1412461","volume":"12","author":"X Sun","year":"2024","unstructured":"Sun X, Xiao C, Wang X, Wu S, Yang Z, Sui B, et al. Role of post-translational modifications of Sp1 in cancer: state of the art. Front Cell Dev Biol. 2024;12:1412461.","journal-title":"Front Cell Dev Biol"},{"key":"8931_CR37","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","volume":"25","author":"Y Sancak","year":"2007","unstructured":"Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA, Spooner E, et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell. 2007;25:903\u201315.","journal-title":"Mol Cell"},{"key":"8931_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41420-024-01862-2","volume":"10","author":"Q Meng","year":"2024","unstructured":"Meng Q, Xie Y, Sun K, He L, Wu H, Zhang Q, et al. ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism reprogramming and immune evasion. Cell Death Discov. 2024;10:97.","journal-title":"Cell Death Discov"},{"key":"8931_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48134-2","volume":"15","author":"T Bhakuni","year":"2024","unstructured":"Bhakuni T, Norden PR, Ujiie N, Tan C, Lee SK, Tedeschi T, et al. FOXC1 regulates endothelial CD98 (LAT1\/4F2hc) expression in retinal angiogenesis and blood-retina barrier formation. Nat Commun. 2024;15:4097.","journal-title":"Nat Commun"},{"key":"8931_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1445472","volume":"15","author":"Z Chen","year":"2024","unstructured":"Chen Z, Cai H, Ye W, Wu J, Liu J, Xie Y, et al. TP63 transcriptionally regulates SLC7A5 to suppress ferroptosis in head and neck squamous cell carcinoma. Front Immunol. 2024;15:1445472.","journal-title":"Front Immunol"},{"key":"8931_CR41","doi-asserted-by":"publisher","first-page":"7525","DOI":"10.1158\/0008-5472.CAN-11-1821","volume":"71","author":"Q Wang","year":"2011","unstructured":"Wang Q, Bailey CG, Ng C, Tiffen J, Thoeng A, Minhas V, et al. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression. Cancer Res. 2011;71:7525\u201336.","journal-title":"Cancer Res"},{"key":"8931_CR42","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.4049\/jimmunol.1300923","volume":"191","author":"K Hayashi","year":"2013","unstructured":"Hayashi K, Jutabha P, Endou H, Sagara H, Anzai N. LAT1 is a critical transporter of essential amino acids for immune reactions in activated human T cells. J Immunol. 2013;191:4080\u20135.","journal-title":"J Immunol"},{"key":"8931_CR43","doi-asserted-by":"publisher","first-page":"9401","DOI":"10.3390\/ijms21249401","volume":"21","author":"A Bouthelier","year":"2020","unstructured":"Bouthelier A, Melendez-Rodriguez F, Urrutia AA, Aragones J. Differential Contribution of N- and C-Terminal Regions of HIF1alpha and HIF2alpha to Their Target Gene Selectivity. Int J Mol Sci. 2020;21:9401.","journal-title":"Int J Mol Sci"},{"key":"8931_CR44","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-22-1270","volume":"83","author":"X Zheng","year":"2023","unstructured":"Zheng X, Sarode P, Weigert A, Turkowski K, Chelladurai P, Gunther S, et al. The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization. Cancer Res. 2023;83:2345\u201357.","journal-title":"Cancer Res"},{"key":"8931_CR45","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10565-021-09679-w","volume":"38","author":"J Gu","year":"2022","unstructured":"Gu J, Sun R, Tang D, Liu F, Chang X, Wang Q. Astragalus mongholicus Bunge-Curcuma aromatica Salisb. suppresses growth and metastasis of colorectal cancer cells by inhibiting M2 macrophage polarization via a Sp1\/ZFAS1\/miR-153-3p\/CCR5 regulatory axis. Cell Biol Toxicol. 2022;38:679\u201397.","journal-title":"Cell Biol Toxicol"},{"key":"8931_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1220","volume":"13","author":"H Pan","year":"2023","unstructured":"Pan H, Guo Z, Lv P, Hu K, Wu T, Lin Z, et al. Proline\/serine-rich coiled-coil protein 1 inhibits macrophage inflammation and delays atherosclerotic progression by binding to Annexin A2. Clin Transl Med. 2023;13:e1220.","journal-title":"Clin Transl Med"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08931-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08931-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08931-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:01:40Z","timestamp":1786629700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08931-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8931"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08931-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"719"}}